CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

CD26 mRNA expression in Systemic Lupus Erythematosus

Credit to Download: 1 | Page Numbers 6 | Abstract Views: 109
Year: 2018
COI code: JR_RHRE-3-2_005
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors CD26 mRNA expression in Systemic Lupus Erythematosus

  Maryam Valizadeh - Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;
  Arman Ahmadzadeh - Department of Rheumatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  Mousa Behzadi - Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;
  Farshid Yeganeh - Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;

Abstract:

Systemic lupus erythematosus (SLE) is a complex autoimmune disease which involves several organs.CD26 is a multifunctional molecule that has an extracellular domain with dipeptidyl peptidase IV activity which digests crucial inflammatory molecules. CD26 plays an important role in T-cell activation and enhances immune responses. This study was carried out to evaluate the level of CD26 gene expression in SLE patients. Forty-six SLE patients and 44 healthy controls voluntarily participated in this study. Based on the SLE disease activity index (SLEDAI), the patients were divided into two subgroups, those with active disease (n=24) and those with inactive disease (n=22). Patients were also subgrouped according to renal involvement, as those with lupus nephritis (n=17) and those without lupus nephritis (n=29). Their CD26 mRNA levels in peripheral blood cells were analyzed by quantitative RT-PCR. CD26 mRNA expression increased 3.6-fold in SLE patients in comparison with the controls (p<0.0001). No difference was found in the level of CD26 mRNA among the subgroups of the SLE patients with the active or inactive form of the disease (p> 0.05). Although CD26 mRNA expression in patients with lupus nephritis was 2.76-fold higher than those without nephritis, the difference was not statistically significant (p> 0.05). CD26 gene expression in peripheral blood cells of SLE patients significantly increased over that of the controls. This increase was not affected by the disease activity nor did it show any significant correlation with complications in organs.

Keywords:

dipeptidyl peptidase IV, Gene expression, Systemic lupus erythematosus

Perma Link

https://www.civilica.com/Paper-JR_RHRE-JR_RHRE-3-2_005.html
COI code: JR_RHRE-3-2_005

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Valizadeh, Maryam; Arman Ahmadzadeh; Mousa Behzadi & Farshid Yeganeh, 2018, CD26 mRNA expression in Systemic Lupus Erythematosus, Rheumatology Research 3 (2), https://www.civilica.com/Paper-JR_RHRE-JR_RHRE-3-2_005.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Valizadeh, Maryam; Arman Ahmadzadeh; Mousa Behzadi & Farshid Yeganeh, 2018)
Second and more: (Valizadeh; Ahmadzadeh; Behzadi & Yeganeh, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.